SRIDEVI DEVARAJ to Cardiovascular Diseases
This is a "connection" page, showing publications SRIDEVI DEVARAJ has written about Cardiovascular Diseases.
Connection Strength
1.698
-
AHA/ACC/Multisociety Cholesterol Guidelines: highlights. Ther Adv Cardiovasc Dis. 2019 Jan-Dec; 13:1753944719881579.
Score: 0.255
-
Leptin: the missing link between obesity and heart disease? Atherosclerosis. 2011 Aug; 217(2):322-3.
Score: 0.151
-
Role of C-reactive protein in contributing to increased cardiovascular risk in metabolic syndrome. Curr Atheroscler Rep. 2010 Mar; 12(2):110-8.
Score: 0.138
-
Statin therapy for the metabolic syndrome: the evidence base. Metab Syndr Relat Disord. 2009 Oct; 7(5):393-6.
Score: 0.134
-
Lipid management in clinical practice. Curr Opin Lipidol. 2009 Aug; 20(4):350-2.
Score: 0.133
-
Statin therapy in acute cardiovascular syndromes. Curr Opin Lipidol. 2007 Oct; 18(5):610-2.
Score: 0.117
-
The role of dietary supplementation with plant sterols and stanols in the prevention of cardiovascular disease. Nutr Rev. 2006 Jul; 64(7 Pt 1):348-54.
Score: 0.107
-
Failure of vitamin E in clinical trials: is gamma-tocopherol the answer? Nutr Rev. 2005 Aug; 63(8):290-3.
Score: 0.101
-
The role of the triglyceride-glucose index as a biomarker of cardio-metabolic syndromes. Lipids Health Dis. 2024 Dec 23; 23(1):416.
Score: 0.097
-
Role of C-reactive protein in the assessment of cardiovascular risk. Am J Cardiol. 2003 Jan 15; 91(2):200-2.
Score: 0.084
-
Performance of novel low-density lipoprotein-cholesterol calculation methods in predicting clinical and subclinical atherosclerotic cardiovascular disease risk: The Multi-Ethnic Study of Atherosclerosis. Atherosclerosis. 2021 06; 327:1-4.
Score: 0.075
-
The effect of increasing tertiles of waist circumference on cardio-metabolic risk, adipokines and biomarkers of inflammation and oxidative stress in nascent metabolic syndrome. J Diabetes Complications. 2018 04; 32(4):379-383.
Score: 0.060
-
Factors that promote macrophage homing to adipose tissue in metabolic syndrome. J Diabetes Complications. 2016 Nov - Dec; 30(8):1434-1436.
Score: 0.054
-
In reply. Clin Chem. 2013 Aug; 59(8):1277-8.
Score: 0.044
-
Association of apolipoprotein B and nuclear magnetic resonance spectroscopy-derived LDL particle number with outcomes in 25 clinical studies: assessment by the AACC Lipoprotein and Vascular Diseases Division Working Group on Best Practices. Clin Chem. 2013 May; 59(5):752-70.
Score: 0.042
-
Dysfunctional endothelial progenitor cells in metabolic syndrome. Exp Diabetes Res. 2012; 2012:585018.
Score: 0.039
-
Apolipoprotein B and cardiovascular disease risk: position statement from the AACC Lipoproteins and Vascular Diseases Division Working Group on Best Practices. Clin Chem. 2009 Mar; 55(3):407-19.
Score: 0.032
-
Increased chemerin and decreased omentin-1 in both adipose tissue and plasma in nascent metabolic syndrome. J Clin Endocrinol Metab. 2013 Mar; 98(3):E514-7.
Score: 0.011
-
Increased cellular and circulating biomarkers of oxidative stress in nascent metabolic syndrome. J Clin Endocrinol Metab. 2012 Oct; 97(10):E1844-50.
Score: 0.010
-
Simvastatin reduces circulating plasminogen activator inhibitor 1 activity in volunteers with the metabolic syndrome. Metab Syndr Relat Disord. 2008 Jun; 6(2):149-52.
Score: 0.008
-
C-reactive protein: risk marker or mediator in atherothrombosis? Hypertension. 2004 Jul; 44(1):6-11.
Score: 0.006